Drug Type Bispecific antibody |
Synonyms PMC-002 |
Target |
Action antagonists, inhibitors |
Mechanism VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists), c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | South Korea | - |